IDEAYA Biosciences, Inc.

    Jurisdiction
    United States
    LEI
    549300ULW08F62IJML11
    ISIN
    US45166A1025 (IDYA)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    49 / 100
    Even with peer group:
    48 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Read full profile

    Fundamentals

    Net revenue
    €5.97M
    Gross margin
    90.8%
    EBIT
    -€327.73M
    EBIT margin
    -5,488.9%
    Net income
    -€282.35M
    Net margin
    -4,729.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €41.12M +588.7% -€264.40M -6.4%
    €113.08M +175.0% -€231.87M -12.3%
    €189.84M +67.9% -€216.11M -6.8%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 358K $5.86M +73K Buy

    Earnings Calls

    Latest earnings call: March 15, 2022 (Q4 2021)

    Add to watchlist

    Notifications